Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Diseases

Free Subscription 11.03.2024 1 AJR Am J Roentgenol 1 Am J Gastroenterol 1 Biochem Biophys Res Commun 4 BMC Cancer 4 BMC Gastroenterol 2 Br J Surg 3 Dig Dis Sci 2 Endoscopy 1 Eur J Pediatr 1 Gastroenterology 1 Gastrointest Endosc 6 Hepatology 1 J Gastroenterol Hepatol 3 J Hepatol 8 PLoS One 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. DEIPOLYI AR, Ward RC, Riaz A, Vogl TJ, et al
   Locoregional Therapies for Primary and Metastatic Breast Cancer: AJR Expert Panel Narrative Review.
   AJR Am J Roentgenol. 2023 Jun 28. doi: 10.2214/AJR.23.29454.
   PubMed         Abstract available
   
   

   
   Am J Gastroenterol

2. HIRODE G, Hansen BE, Chen CH, Su TH, et al
   Erratum: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
   Am J Gastroenterol. 2024 Mar 8. doi: 10.14309/ajg.0000000000002718.
   PubMed        
   
   

   
   Biochem Biophys Res Commun

3. HUANG W, Qian Y, Lin J, Wang F, et al
   Baicalein alleviates intrahepatic cholestasis by regulating bile acid metabolism via an FXR-dependent manner.
   Biochem Biophys Res Commun. 2024;705:149670.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. LIANG Y, Zhong D, Zhang Z, Su Y, et al
   Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma.
   BMC Cancer. 2024;24:291.
   PubMed         Abstract available
   
   
5. HUANG JX, Zhang X, Tang M, Zhang Q, et al
   Comprehensive evaluation of serum hepatic proteins in predicting prognosis among cancer patients with cachexia: an observational cohort study.
   BMC Cancer. 2024;24:293.
   PubMed         Abstract available
   
   
6. WONGLHOW J, Sunpaweravong P, Sathitruangsak C, Dechaphunkul A, et al
   LABS score- a prognostic tool for FOLFOX4-treated advanced hepatocellular carcinoma and real-world efficacy: a single-center retrospective study.
   BMC Cancer. 2024;24:281.
   PubMed         Abstract available
   
   
7. LIN J, Li J, Kong Y, Yang J, et al
   Construction of a prognostic model for hepatocellular carcinoma patients receiving transarterial chemoembolization treatment based on the Tumor Burden Score.
   BMC Cancer. 2024;24:306.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

8. KILONZO SB, Kamala E, Jaka H, Ngoya P, et al
   Non-alcoholic fatty liver disease in Tanzania: prevalence, determinants, and diagnostic performance of triglycerides-glucose index and triglycerides-glucose index -body mass index compared to the hepatic ultrasound in overweight and obese individuals.
   BMC Gastroenterol. 2024;24:96.
   PubMed         Abstract available
   
   
9. LIU B, Dou J, Cao J
   Nuclear respiratory factor 1 regulates super enhancer-controlled SPIDR to protect hepatocellular carcinoma cells from oxidative stress.
   BMC Gastroenterol. 2024;24:97.
   PubMed         Abstract available
   
   
10. LIU C, Li Z, Zhang Z, Li J, et al
    Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
    BMC Gastroenterol. 2024;24:93.
    PubMed         Abstract available
    
    
11. FANG G, Liu S, Liu B
    Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with differential application dosages and strategies: a network meta-analysis.
    BMC Gastroenterol. 2024;24:94.
    PubMed         Abstract available
    
    

    
    Br J Surg

12. PENG W, Wu Y, Zhang X, Li C, et al
    Liver transplantation for advanced hepatocellular carcinoma after downstaging with consequential lenvatinib, transcatheter arterial chemoembolization and camrelizumab.
    Br J Surg. 2024;111:znae048.
    PubMed        
    
    
13. FAN ZQ, Serenari M, Lv X, Schwartz M, et al
    Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma.
    Br J Surg. 2024;111:znae047.
    PubMed        
    
    

    
    Dig Dis Sci

14. PETROSYAN R, Endres P, Ufere NN, St Hillien SA, et al
    Healthcare Resource Utilization and Goals of Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
    Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08317.
    PubMed         Abstract available
    
    
15. PATEL AA, Walling A, Bansal A
    A New Look at Goals-of-Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
    Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08300.
    PubMed        
    
    
16. REN J, Yao X, Yang M, Cheng S, et al
    Kinesin Family Member-18A (KIF18A) Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma.
    Dig Dis Sci. 2024 Mar 6. doi: 10.1007/s10620-024-08321.
    PubMed         Abstract available
    
    

    
    Endoscopy

17. SORGE A, Pessarelli T, Elli L, Nandi N, et al
    Band-on-band endoscopic variceal ligation: a technique for the treatment of esophageal varices in case of band misplacement.
    Endoscopy. 2024;56.
    PubMed        
    
    
18. BINDA C, Dajti E, Giuffrida P, Trebbi M, et al
    Efficacy and safety of endoscopic ultrasound-guided hepatico-gastrostomy: a meta-regression analysis.
    Endoscopy. 2024 Mar 6. doi: 10.1055/a-2282-3350.
    PubMed         Abstract available
    
    

    
    Eur J Pediatr

19. DE CUEVILLAS B, Lubrecht J, Navas-Carretero S, Vreugdenhil A, et al
    Sleep duration is associated with liver steatosis in children depending on body adiposity.
    Eur J Pediatr. 2024;183:779-789.
    PubMed         Abstract available
    
    

    
    Gastroenterology

20. WONG RJ, Yang Z, Cheung R, Singal AK, et al
    Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among U.S. Veterans with Steatotic Liver Disease.
    Gastroenterology. 2024 Feb 28:S0016-5085(24)00238.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

21. WANG TJ, Jirapinyo P, Shah R, Schuster K, et al
    Endoscopic Ultrasound Guided Liver Palpation As a Screening Tool for Advanced Fibrosis and Cirrhosis in Patients with Suspected Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pilot Study.
    Gastrointest Endosc. 2024 Feb 29:S0016-5107(24)00137.
    PubMed         Abstract available
    
    

    
    Hepatology

22. GUO Q, Wang J, Wang G, Wang X, et al
    Letter to the Editor: Is right heart assessment vital for evaluating Terlipressin-related outcomes in Hepatorenal Syndrome-AKI?
    Hepatology. 2024 Mar 8. doi: 10.1097/HEP.0000000000000832.
    PubMed        
    
    
23. BERENGUER J, Aldamiz-Echevarria T, Hontanon V, Fanciulli C, et al
    Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV coinfected patients with advanced Fibrosis/Cirrhosis.
    Hepatology. 2024 Mar 7. doi: 10.1097/HEP.0000000000000838.
    PubMed         Abstract available
    
    
24. SEMMLER G, Hartl L, Mendoza YP, Simbrunner B, et al
    Simple blood tests to diagnose compensated advanced chronic liver disease and stratify risk of clinically significant portal hypertension.
    Hepatology. 2024 Mar 6. doi: 10.1097/HEP.0000000000000829.
    PubMed         Abstract available
    
    
25. AMPUERO J, Lucena A, Berenguer M, Hernandez-Guerra M, et al
    Predictive factors for decompensating events in cirrhotic patients with primary biliary cholangitis under different lines of therapy.
    Hepatology. 2024 Mar 6. doi: 10.1097/HEP.0000000000000826.
    PubMed         Abstract available
    
    
26. ROY A, Kajal K, Izzy M, Sihag BK, et al
    Reply: Is right heart assessment vital for evaluating terlipressin-related outcomes in Hepatorenal Syndrome-AKI ?
    Hepatology. 2024 Mar 5. doi: 10.1097/HEP.0000000000000833.
    PubMed        
    
    
27. KUMAR M, Venishetty S, Jindal A, Bihari C, et al
    Tranexamic acid in upper gastrointestinal bleed in patients with cirrhosis - a randomized controlled trial.
    Hepatology. 2024 Mar 5. doi: 10.1097/HEP.0000000000000817.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

28. BALE G, Kulkarni AV, Padaki NR, Menon PB, et al
    Comparing rare variants versus common in the pathogenesis of nonalcoholic fatty liver disease: a whole exome sequencing approach.
    J Gastroenterol Hepatol. 2024;39:587-595.
    PubMed         Abstract available
    
    

    
    J Hepatol

29. ROCA-FERNANDEZ A, Banerjee R, Thomaides-Brears H, Telford A, et al
    Liver disease is a significant risk factor for cardiovascular outcomes - A UK Biobank study.
    J Hepatol. 2023;79:1085-1095.
    PubMed         Abstract available
    
    
30. LEI Z, Yu J, Wu Y, Shen J, et al
    CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis.
    J Hepatol. 2024;80:194-208.
    PubMed         Abstract available
    
    
31. ZHANG Q, Wei T, Jin W, Yan L, et al
    Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
    J Hepatol. 2024;80:293-308.
    PubMed         Abstract available
    
    

    
    PLoS One

32. DUHRING S, Schuster S
    Studying mixed-species biofilms of Candida albicans and Staphylococcus aureus using evolutionary game theory.
    PLoS One. 2024;19:e0297307.
    PubMed         Abstract available
    
    
33. CHEN Q, Sun Q, Zhang J, Li B, et al
    Cost-effectiveness analysis of Tislelizumab vs Sorafenib as the first-line treatment of unresectable hepatocellular carcinoma.
    PLoS One. 2024;19:e0295090.
    PubMed         Abstract available
    
    
34. STAUFFER WT, Goodman AZ, Bobardt M, Ure DR, et al
    Mice lacking cyclophilin B, but not cyclophilin A, are protected from the development of NASH in a diet and chemical-induced model.
    PLoS One. 2024;19:e0298211.
    PubMed         Abstract available
    
    
35. YANG Y, Mirzaei G
    Performance analysis of data resampling on class imbalance and classification techniques on multi-omics data for cancer classification.
    PLoS One. 2024;19:e0293607.
    PubMed         Abstract available
    
    
36. LI YS, Xia YG, Liu YL, Jiang WR, et al
    Metabolic-dysfunction associated steatotic liver disease-related diseases, cognition and dementia: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0297883.
    PubMed         Abstract available
    
    
37. MCTEER M, Applegate D, Mesenbrink P, Ratziu V, et al
    Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information.
    PLoS One. 2024;19:e0299487.
    PubMed         Abstract available
    
    
38. NAH EH, Choi YJ, Cho S, Park H, et al
    Changes in nonalcoholic fatty liver disease and M2BPGi due to lifestyle intervention in primary healthcare.
    PLoS One. 2024;19:e0298151.
    PubMed         Abstract available
    
    
39. BUDZYNSKA A, Kubik A, Kacperski K, Pastusiak P, et al
    PET/CT and SPECT/CT imaging of 90Y hepatic radioembolization at therapeutic and diagnostic activity levels: Anthropomorphic phantom study.
    PLoS One. 2024;19:e0271711.
    PubMed         Abstract available
    
    

    
    Transplant Proc

40. IMAOKA K, Ohira M, Hattori M, Chogahara I, et al
    Immunotherapy Using Activated Natural Killer Cells Improves Postoperative Neutrophil-to-Lymphocyte Ratio and Long-Term Prognosis of Living Donor Liver Transplant Recipients With Hepatocellular Carcinoma.
    Transplant Proc. 2024 Mar 4:S0041-1345(24)00129.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.